NIH funds Ohio University faculty research into extending lifespan

(Ohio University) The project builds on Dr. John Kopchick's builds past research in growth hormone, which led to the discovery of the GH receptor antagonist drug, pegvisomant (trade name Somavert®).

from EurekAlert! - Social and Behavioral Science https://ift.tt/2MNFsax